Office of Responsible Research Practices
The Ohio State University

FDA Regulated Research: Innovation & Compliance

The Ohio State University Office of Responsible Research Practices in collaboration with the Center for Clinical and Translational Science and Nationwide Children’s Hospital will host an FDA-focused conference entitled “FDA Regulated Research: Innovation & Compliance.”  The conference will host a number of speakers from industry, regulatory experts, The Ohio State University, Wexner Medical Center, Comprehensive Cancer Center, and Nationwide Children’s Hospital and will focus on the following key topics:

  • Drug Development and Innovation
  • Device Innovation
  • Investigator Responsibilities
  • Partnerships with Industry
  • Innovation and Drug Development Strategies
  • Keys to Successful Translational Research
  • FDA Inspections
  • Research Resources Panel Discussion

This event has reached capacity.  Registration is closed.

Contact: John Yocom at yocom.9@osu.edu.


Who: Anyone interested in FDA regulated research
When: March 3, 2017, 8:15 a.m. – 3:30 p.m.
Registration opens at 7:30 a.m.
Where: The Ohio State University
Biomedical Research Tower, Room 115

Attendance at this event has been pre‐approved for contact hours of clinical research-related education on applications for Maintenance of ACRP’s CCRC®, CCRA®, or CPI® certification designations.